Patients with LAPTM4B *1 (genotypes *1/1) had a significantly poorer overall survival when compared with LAPTM4B *2 (genotypes *1/2 or *2/2) patients in colon cancer (discovery and testing cohorts), but not in rectal and esophageal cancers. Here, LAPTM4B is linked to esophageal cancer.